pcDNA5FRT_KCNQ3
(Plasmid
#173163)
-
PurposeTo generate Flp-In CHO-KCNQ3 stable cells
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 173163 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepcDNA5/FRT
-
Backbone manufacturerInvitrogen
- Backbone size w/o insert (bp) 5130
- Total vector size (bp) 7748
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameKCNQ3
-
Alt nameKv7.3
-
SpeciesH. sapiens (human)
-
Insert Size (bp)2618
-
Entrez GeneKCNQ3 (a.k.a. BFNC2, EBN2, KV7.3)
- Promoter CMV
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site unknown (unknown if destroyed)
- 3′ cloning site unknown (unknown if destroyed)
- 5′ sequencing primer CMV_F
- 3′ sequencing primer BGH_R (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pcDNA5FRT_KCNQ3 was a gift from Al George (Addgene plasmid # 173163 ; http://n2t.net/addgene:173163 ; RRID:Addgene_173163) -
For your References section:
High-throughput evaluation of epilepsy-associated KCNQ2 variants reveals functional and pharmacological heterogeneity. Vanoye CG, Desai RR, Ji Z, Adusumilli S, Jairam N, Ghabra N, Joshi N, Fitch E, Helbig KL, McKnight D, Lindy AS, Zou F, Helbig I, Cooper EC, George AL Jr. JCI Insight. 2022 Mar 8;7(5):e156314. doi: 10.1172/jci.insight.156314. 10.1172/jci.insight.156314 PubMed 35104249